We are live on ! Find out more
ACET icon

Adicet Bio
ACET

44 hedge funds and large institutions have $134M invested in Adicet Bio in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

38% more funds holding

Funds holding: 32 → 44 (+12)

25% more capital invested

Capital invested by funds: $108M → $134M (+$26.4M)

0.1% more ownership

Funds ownership: 2.93% → 3.04% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
44
Holders Change
+12
Holders Change %
+37.5%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
12
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.46M
2
BlackRock
BlackRock
New York
+$1.8M
3
JGC
J. Goldman & Co
New York
+$1.3M
4
ECM
ExodusPoint Capital Management
New York
+$607K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$485K

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$1.28M
2
NCM
Nantahala Capital Management
Connecticut
-$911K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$797K
4
AC
AWH Capital
Texas
-$357K
5
EWM
Edge Wealth Management
New York
-$156K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$217K – – –
GSEP
27
Golden State Equity Partners
California
$184K +$168K +822 New
Citigroup
28
Citigroup
New York
$163K +$144K +705 +3,711%
Goldman Sachs
29
Goldman Sachs
New York
$144K +$131K +640 New
Wells Fargo
30
Wells Fargo
California
$130K +$119K +581 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$13K +$614 +3 +5%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$13K +$11.7K +57 New
TRCT
33
Tower Research Capital (TRC)
New York
$11K -$20.1K -98 -68%
UBS Group
34
UBS Group
Switzerland
$8K -$10.7K -52 -59%
Bank of America
35
Bank of America
North Carolina
$6K -$24.2K -118 -81%
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$6K +$5.12K +25 New
PCM
37
Penserra Capital Management
California
$6K +$5.12K +25 +833%
JP Morgan Chase
38
JP Morgan Chase
New York
$5K +$4.92K +24 New
Fifth Third Bancorp
39
Fifth Third Bancorp
Ohio
$2K +$1.84K +9 New
Federated Hermes
40
Federated Hermes
Pennsylvania
$1K -$2.46K -12 -75%
OSAM
41
O'Shaughnessy Asset Management
Connecticut
$1K – – –
AC
42
AWH Capital
Texas
– -$357K -10,625 Closed
EWM
43
Edge Wealth Management
New York
– -$156K -822 Closed
Fidelity Investments
44
Fidelity Investments
Massachusetts
– +$410 +2 New
1
2

ACET Hedge Fund Activity: Q4 2020 in Review

44 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q4 2020, worth a combined $134M — up 25% from $108M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ACET positions and 2 closed out — a net gain of 12 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.46M. The largest seller was Ikarian Capital, cutting an estimated $1.28M.

  • 44 institutional investors held Adicet Bio (ACET) as of Q4 2020, up from 32 in Q3 2020.
  • Funds reported $134M of Adicet Bio stock for Q4 2020, up 25% quarter-over-quarter.
  • 14 funds opened new Adicet Bio positions in Q4 2020 and 2 closed out, a net change of +12 holders.
  • The largest Adicet Bio buyer in Q4 2020 was Vanguard Group, an estimated $3.46M added.
  • The largest Adicet Bio seller in Q4 2020 was Ikarian Capital, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2020.